Bristol Gate Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.64M |
| 2 |
UnitedHealth
UNH
|
+$3.43M |
| 3 |
Visa
V
|
+$3M |
| 4 |
Texas Instruments
TXN
|
+$2.93M |
| 5 |
Broadridge
BR
|
+$2.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tyson Foods
TSN
|
+$1.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.91% |
| 2 | Financials | 17.8% |
| 3 | Healthcare | 13.54% |
| 4 | Industrials | 9.45% |
| 5 | Consumer Discretionary | 9.19% |
Similar funds
Bristol Gate Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Bristol Gate Capital Partners held 34 positions worth $1.51B, up 14% from $1.32B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Bristol Gate Capital Partners deployed $66M of net new capital in Q4 2020, opening 1 new position and adding to 32 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 18,730 shares worth $7.01M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Tyson Foods, an estimated $1.42M trimmed.
- Bristol Gate Capital Partners's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 18,730 shares worth $7.01M.
- Bristol Gate Capital Partners added most to UnitedHealth in Q4 2020, an estimated $3.43M increase.
- Bristol Gate Capital Partners's biggest Q4 2020 reduction was Tyson Foods, cutting an estimated $1.42M.
- Bristol Gate Capital Partners's ten largest holdings make up 48% of its $1.51B portfolio in Q4 2020.
- Bristol Gate Capital Partners opened 1 new position and closed 0 in Q4 2020.
- Bristol Gate Capital Partners's portfolio value rose 14% quarter-over-quarter to $1.51B.
Based on Bristol Gate Capital Partners's 13F filing for Q4 2020, filed 12 Feb 2021.